TriSalus Life Sciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $252.0M
Liabilities Breakdown FY2020
Total Liabilities: $23.5M
Asset Breakdown
Total Assets: $252.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.3M | 0.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $250.7M | 99.5% |
Liabilities Breakdown
Total Liabilities: $23.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $23.5M | 100.0% |